Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹893.40.
30 Oct: open ₹893.45, high ₹893.45, low ₹830.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,009 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 88,12456.8% delivered
Orchid Pharma share news and announcements
856 announcements, routine notices left out, newest first. Page 6 of 18.
Apr 2022
Mar 2022
24 Mar · Communication to shareholders as per Reg 30
16 Mar · Communication to shareholders as per Reg 30
Feb 2022
14 Feb · Updates
12 Feb · Results
12 Feb · Board meeting
11 Feb · Analysts
Jan 2022
20 Jan · Disclosure
Dec 2021
25 Dec · Rating
20 Dec · Analysts
14 Dec · Updates
7 Dec · Business
1 Dec · Corrigendum
Nov 2021
30 Nov · Related Party Transactions
14 Nov · Results
14 Nov · Board meeting
9 Nov · Updates
1 Nov · Updates
Oct 2021
8 Oct · Disclosure
1 Oct · Legal
Exchange has sought clarification from Orchid Pharma Limited with respect to announcement dated 30-Sep-2021, regarding Credit Rating. On basis of above the Company is required to clarify following: 1. Promptly notify the Exchange, but not later than 24 hours2. In case of downward rating, the disclosure may include reasons published by rating agency for such downward rating.The response of the Company is awaited.
Sep 2021
30 Sep · Rating
Aug 2021
14 Aug · Updates
13 Aug · Results
13 Aug · Board meeting
6 Aug · Board meeting
Jul 2021
15 Jul · Board meeting
12 Jul · Board meeting